Amoxycare 200 mg Tablets

Šalis: Didžioji Britanija

kalba: anglų

Šaltinis: VMD (Veterinary Medicines Directorate)

Veiklioji medžiaga:

Amoxicillin

Prieinama:

Norbrook Laboratories Limited

ATC kodas:

QJ01CA04

INN (Tarptautinis Pavadinimas):

Amoxicillin

Vaisto forma:

Tablet

Recepto tipas:

POM-V - Prescription Only Medicine – Veterinarian

Farmakoterapinė grupė:

Cats, Dogs

Gydymo sritis:

Antimicrobial

Autorizacija statusas:

Expired

Leidimo data:

1997-12-29

Prekės savybės

Revised: 10
th
December 2008
AN: 00495/2008
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Amoxycare 200mg Tablets.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Each tablet contains Amoxicillin (as Amoxicillin Trihydrate) 200 mg.
EXCIPIENTS:
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Tablet.
Off-white circular tablets scored on one face.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
Cats
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For use in the treatment of bacterial infections of the alimentary,
respiratory
and urogenital tracts and in eye, ear, skin and wound infections
caused by
susceptible organisms. _ In vitro_ amoxicillin is effective against a
range of
Gram-positive and Gram-negative bacteria, including:
_Bacillus cereus_
_Bordetella bronchiseptica_
Corynebacterium spp
_Citrobacter freundii_
Chromobacter spp
_Escherichia coli_
Flavobacter spp
_Proteus mirabilis_
Pasteurella spp including _Pasteurella multocida_
Salmonella spp
Staphylococci (penicillin sensitive strains)
Streptococci
Revised: 10
th
December 2008
AN: 00495/2008
4.3
CONTRAINDICATIONS
Amoxycare 200mg Tablets should not be given to penicillin sensitive
animals.
As with other penicillins, amoxicillin should not be used orally or
parenterally
in rabbits, guinea pigs, hamsters or gerbils. Caution is advised when
used in
other very small herbivores.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
No special warnings.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the
bacteria
isolated from the animal. If this is not possible, therapy should be
based on
local epidemiological information.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
Penicillin’s and cephalosporins may cause hypersensitivity (allergy)
following
injection, inhalation, ingestion or skin contact. Hypersensitivity to
penicillins
may lead to cross-reactions